
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
STI-6991 is an I-CellTM COVID-19 cellular vaccine made of replication-deficient human erythroleukemia K562 cells expressing membrane-bound S1 protein of the SARS-CoV-2 virus The I-Cell vaccine is expected to elicit both T cell and B cell immunities against …